Tamarly Intelligence
Private raises · SEC Form D

Auron Therapeutics, Inc.: $27 million Raised, SEC Form D Filings

Company · Biotechnology · MA · SEC CIK 1746139

Form D notices

A Form D tells the SEC that an issuer sold securities without a public offering. Amounts are as the issuer reported them; an amendment updates an earlier notice.

FiledTypeOfferingSoldIndustry
13 Aug 2026New notice$12 million$7 millionBiotechnologyForm D
23 Dec 2025Amendment$42 million$27 millionBiotechnologyForm D

Questions and answers

How much has Auron Therapeutics, Inc. raised?
Auron Therapeutics, Inc. reported $27 million sold in its largest Form D notice on file; its latest notice was filed on 13 August 2026. Form D amounts are what the issuer reported to the SEC.
What is Auron Therapeutics, Inc.?
Auron Therapeutics, Inc. is a company in biotechnology, based in Wellesley, Massachusetts, according to its SEC Form D filings.
How many Form D notices has Auron Therapeutics, Inc. filed?
2 notices between 23 December 2025 and 13 August 2026 in Tamarly's record, which starts on 1 October 2025.
Get an alert when Auron Therapeutics, Inc. files again, and see every Form D raise as it arrives; the 7-day trial opens everything.Start the free trial

Source: SEC EDGAR, Form D (public domain). Cite this page: Tamarly Intelligence, "Auron Therapeutics, Inc.: SEC Form D filings", https://app.tamarly.ai/raisers/1746139, built from SEC EDGAR.

Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.